https://www.selleckchem.com/pr....oducts/chk2-inhibito
0; 95% CI -4.75 to 0.71; P=0.0162 for NI); +4.3 (13.4) vs +7.9 (11.9) letters (W0-104). Mean (SD) number of injections was 12.0 (2.3) vs 13.0 (1.8). From baseline to W104, 93.4% and 96.2% maintained BCVA; mean (SD) central retinal thickness change was -161.6 (135.6) µm and -158.6 (125.1) µm. Last injection interval (W104) was ≥12W for 47.2% and 51.9% of patients. Outcomes were similar between patients with nAMD treated with an IVT-AFL early- or late-TE regimen following initial dosing, with one injection difference
Like
Comment
Share
